메뉴 건너뛰기




Volumn 18, Issue 5, 2004, Pages 1183-1206

The role of imaging in the clinical development of antiangiogenic agents

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; ANGIOGENESIS INHIBITOR; CONTRAST MEDIUM; VATALANIB;

EID: 5044226920     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.06.011     Document Type: Review
Times cited : (14)

References (89)
  • 1
    • 0030976173 scopus 로고    scopus 로고
    • Cancer undefeated
    • J.C. Bailar, and H.L. Gornik Cancer undefeated N Engl J Med 336 22 1997 1569 1574
    • (1997) N Engl J Med , vol.336 , Issue.22 , pp. 1569-1574
    • Bailar, J.C.1    Gornik, H.L.2
  • 2
    • 0033617532 scopus 로고    scopus 로고
    • Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
    • G. Bergers, K. Javaherian, K.M. Lo, J. Folkman, and D. Hanahan Effects of angiogenesis inhibitors on multistage carcinogenesis in mice Science 284 1999 808 812
    • (1999) Science , vol.284 , pp. 808-812
    • Bergers, G.1    Javaherian, K.2    Lo, K.M.3    Folkman, J.4    Hanahan, D.5
  • 3
    • 0029944122 scopus 로고    scopus 로고
    • Angiostatin induces and sustains dormancy of human primary tumors in mice
    • M.S. O'Reilly, L. Holmgren, C. Chen, and J. Folkman Angiostatin induces and sustains dormancy of human primary tumors in mice Nat Med 2 1996 689 692
    • (1996) Nat Med , vol.2 , pp. 689-692
    • O'Reilly, M.S.1    Holmgren, L.2    Chen, C.3    Folkman, J.4
  • 4
    • 0034244239 scopus 로고    scopus 로고
    • Prolonged stable disease effects survival in patients with solid gastric tumor: Analysis of phase II studies of doxifluridine
    • Y. Takahashi, M. Mai, T. Taguchi, I. Urushizaki, and K. Nishioka Prolonged stable disease effects survival in patients with solid gastric tumor: analysis of phase II studies of doxifluridine Int J Oncol 17 2000 285 289
    • (2000) Int J Oncol , vol.17 , pp. 285-289
    • Takahashi, Y.1    Mai, M.2    Taguchi, T.3    Urushizaki, I.4    Nishioka, K.5
  • 7
    • 0003286786 scopus 로고    scopus 로고
    • Surrogate markers for the assessment of biological activity of the VEGF-receptor inhibitor PTK787/ZK 222584 (PTK/ZK) in two clinical phase I trials
    • J. Drevs, C.I. Schmidt-Gersbach, K. Mross, M. Medinger, M. Mueller, and W. Steward Surrogate markers for the assessment of biological activity of the VEGF-receptor inhibitor PTK787/ZK 222584 (PTK/ZK) in two clinical phase I trials Proc Am Soc Clin Oncol 21 2002 a337
    • (2002) Proc Am Soc Clin Oncol , vol.21
    • Drevs, J.1    Schmidt-Gersbach, C.I.2    Mross, K.3    Medinger, M.4    Mueller, M.5    Steward, W.6
  • 8
    • 0034092011 scopus 로고    scopus 로고
    • Tumor angiogenesis: Past, present and the near future
    • R.S. Kerbel Tumor angiogenesis: past, present and the near future Carcinogenesis 21 2000 505 515
    • (2000) Carcinogenesis , vol.21 , pp. 505-515
    • Kerbel, R.S.1
  • 10
    • 0037440123 scopus 로고    scopus 로고
    • Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors
    • J.P. Thomas, R.Z. Arzoomanian, D. Alberti, R. Marnocha, F. Lee, and A. Friedl Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors J Clin Oncol 21 2 2003 223 231
    • (2003) J Clin Oncol , vol.21 , Issue.2 , pp. 223-231
    • Thomas, J.P.1    Arzoomanian, R.Z.2    Alberti, D.3    Marnocha, R.4    Lee, F.5    Friedl, A.6
  • 11
    • 0028470454 scopus 로고
    • Barriers to drug delivery in solid tumors
    • R.K. Jain Barriers to drug delivery in solid tumors Sci Educ Bull 271 1994 58 65
    • (1994) Sci Educ Bull , vol.271 , pp. 58-65
    • Jain, R.K.1
  • 14
    • 0036136820 scopus 로고    scopus 로고
    • Translating molecular imaging
    • B.J. Hillman, and H.L. Neiman Translating molecular imaging Radiology 222 2002 19 24
    • (2002) Radiology , vol.222 , pp. 19-24
    • Hillman, B.J.1    Neiman, H.L.2
  • 15
    • 0035884219 scopus 로고    scopus 로고
    • Clinical trials of antiangiogenic drugs: Opportunities, problems, and assessment of initial results
    • R.S. Kerbel Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results J Clin Oncol 19 18s 2001 45s 51s
    • (2001) J Clin Oncol , vol.19 , Issue.18
    • Kerbel, R.S.1
  • 16
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • P. Carmeliet, and R. Jain Angiogenesis in cancer and other diseases Nature 407(6801) 2000 249 257
    • (2000) Nature , vol.407 , Issue.6801 , pp. 249-257
    • Carmeliet, P.1    Jain, R.2
  • 17
    • 0036842215 scopus 로고    scopus 로고
    • Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
    • H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 21 2002 4368 4380
    • (2002) J Clin Oncol , vol.20 , Issue.21 , pp. 4368-4380
    • Dvorak, H.F.1
  • 18
    • 0031443206 scopus 로고    scopus 로고
    • A cancer therapy resistant to resistance
    • R.S. Kerbel A cancer therapy resistant to resistance Nature 390 1997 335 336
    • (1997) Nature , vol.390 , pp. 335-336
    • Kerbel, R.S.1
  • 19
    • 0037093249 scopus 로고    scopus 로고
    • Influence of unrecognized molecular heterogeneity on randomized clinical trials
    • R.A. Betensky, D.N. Louis, and J.G. Cairncross Influence of unrecognized molecular heterogeneity on randomized clinical trials J Clin Oncol 20 2002 2495 2499
    • (2002) J Clin Oncol , vol.20 , pp. 2495-2499
    • Betensky, R.A.1    Louis, D.N.2    Cairncross, J.G.3
  • 20
    • 0035100888 scopus 로고    scopus 로고
    • Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    • Biomarkers Definitions Working Group Bethesda
    • Biomarkers Definitions Working Group Bethesda Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 3 2001 89 95
    • (2001) Clin Pharmacol Ther , vol.69 , Issue.3 , pp. 89-95
  • 21
    • 0031886171 scopus 로고    scopus 로고
    • Tumors characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights
    • M.Y. Su, A. Muhler, X. Lao, and O. Nalcioglu Tumors characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights Magn Reson Med 39 2 1998 259 269
    • (1998) Magn Reson Med , vol.39 , Issue.2 , pp. 259-269
    • Su, M.Y.1    Muhler, A.2    Lao, X.3    Nalcioglu, O.4
  • 22
    • 0032828135 scopus 로고    scopus 로고
    • Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: Standardized quantities and symbols
    • P.S. Tofts, G. Brix, D.L. Buckley, J.L. Evelhoch, E. Henderson, and M.V. Knopp Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols J Magn Reson Imaging 10 3 1999 223 232
    • (1999) J Magn Reson Imaging , vol.10 , Issue.3 , pp. 223-232
    • Tofts, P.S.1    Brix, G.2    Buckley, D.L.3    Evelhoch, J.L.4    Henderson, E.5    Knopp, M.V.6
  • 23
    • 0029787388 scopus 로고    scopus 로고
    • Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis
    • L.D. Buadu, J. Murakami, S. Murayama, N. Hashiguchi, S. Sakai, and K. Masuda Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis Radiology 200 3 1996 639 649
    • (1996) Radiology , vol.200 , Issue.3 , pp. 639-649
    • Buadu, L.D.1    Murakami, J.2    Murayama, S.3    Hashiguchi, N.4    Sakai, S.5    Masuda, K.6
  • 24
    • 0031723118 scopus 로고    scopus 로고
    • Angiogenic activity of cervical carcinoma: Assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome
    • H. Hawighorst, P.G. Knapstein, M.V. Knopp, and W. Weikel Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome Clin Cancer Res 4 10 1998 2305 2312
    • (1998) Clin Cancer Res , vol.4 , Issue.10 , pp. 2305-2312
    • Hawighorst, H.1    Knapstein, P.G.2    Knopp, M.V.3    Weikel, W.4
  • 25
    • 0031912025 scopus 로고    scopus 로고
    • Prediction of tumor control in patients with cervical cancer: Analysis of combined volume and dynamic enhancement pattern by MR imaging
    • N.A. Mayr, W.T. Yuh, J. Zheng, J.C. Ehrhardt, V.A. Magnotta, and J.I. Sorosky Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging Am J Roentgenol 170 1 1998 177 182
    • (1998) Am J Roentgenol , vol.170 , Issue.1 , pp. 177-182
    • Mayr, N.A.1    Yuh, W.T.2    Zheng, J.3    Ehrhardt, J.C.4    Magnotta, V.A.5    Sorosky, J.I.6
  • 27
    • 0030657917 scopus 로고    scopus 로고
    • Dynamic echo-planar imaging of the breast: Experience in diagnosing breast carcinoma and correlation with tumor angiogenesis
    • C.A. Hulka, W.B. Edmister, B.L. Smith, L. Tan, D.C. Sgroi, and T. Campbell Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis Radiology 205 3 1997 837 842
    • (1997) Radiology , vol.205 , Issue.3 , pp. 837-842
    • Hulka, C.A.1    Edmister, W.B.2    Smith, B.L.3    Tan, L.4    Sgroi, D.C.5    Campbell, T.6
  • 28
    • 0032863707 scopus 로고    scopus 로고
    • Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma
    • W.E. Reddick, J.S. Taylor, and B.D. Fletcher Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma J Magn Reson Imaging 10 3 1999 277 285
    • (1999) J Magn Reson Imaging , vol.10 , Issue.3 , pp. 277-285
    • Reddick, W.E.1    Taylor, J.S.2    Fletcher, B.D.3
  • 29
    • 0031946469 scopus 로고    scopus 로고
    • Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor
    • C.D. Pham, T.P. Roberts, N. van Bruggen, O. Melnyk, J. Mann, and N. Ferrara Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor Cancer Invest 16 4 1998 225 230
    • (1998) Cancer Invest , vol.16 , Issue.4 , pp. 225-230
    • Pham, C.D.1    Roberts, T.P.2    Van Bruggen, N.3    Melnyk, O.4    Mann, J.5    Ferrara, N.6
  • 31
    • 0032968340 scopus 로고    scopus 로고
    • Improved delineation of human brain tumors on MR images using a long-circulating superparamagnetic iron oxide agent
    • W.S. Enochs, G. Harsh, F. Hochberg, and R. Weissleder Improved delineation of human brain tumors on MR images using a long-circulating superparamagnetic iron oxide agent J Magn Reson Imaging 9 1999 228 232
    • (1999) J Magn Reson Imaging , vol.9 , pp. 228-232
    • Enochs, W.S.1    Harsh, G.2    Hochberg, F.3    Weissleder, R.4
  • 32
    • 0037612351 scopus 로고    scopus 로고
    • New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer
    • J. Rydland, A. Bjornerud, O.A. Haugen, G. Torheim, C. Torres, and K.A. Kvistad New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer Acta Radiol 44 3 2003 275 283
    • (2003) Acta Radiol , vol.44 , Issue.3 , pp. 275-283
    • Rydland, J.1    Bjornerud, A.2    Haugen, O.A.3    Torheim, G.4    Torres, C.5    Kvistad, K.A.6
  • 33
    • 0347615101 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases
    • B. Morgan, A.L. Thomas, J. Drevs, J. Hennig, M. Buchert, and A. Jivan Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases J Clin Oncol 21 2003 3955 3964
    • (2003) J Clin Oncol , vol.21 , pp. 3955-3964
    • Morgan, B.1    Thomas, A.L.2    Drevs, J.3    Hennig, J.4    Buchert, M.5    Jivan, A.6
  • 35
    • 0042519916 scopus 로고    scopus 로고
    • A phase I trial of single-agent PTK 787/ZK 222584 (PTK/ZK), an oral VEGFR tyrosine kinase inhibitor, in patients with recurrent glioblastoma multiforme [abstract]
    • W.K.A. Yung, H. Friedman, C. Conrad, D. Reardon, J. Provenzale, and E. Jackson A phase I trial of single-agent PTK 787/ZK 222584 (PTK/ZK), an oral VEGFR tyrosine kinase inhibitor, in patients with recurrent glioblastoma multiforme [abstract] Proc Am Soc Clin Oncol 22 2003 99
    • (2003) Proc Am Soc Clin Oncol , vol.22 , pp. 99
    • Yung, W.K.A.1    Friedman, H.2    Conrad, C.3    Reardon, D.4    Provenzale, J.5    Jackson, E.6
  • 36
    • 0642281450 scopus 로고    scopus 로고
    • Antiangiogenic therapy: More promise and, yet again, more questions
    • L.M. Ellis Antiangiogenic therapy: more promise and, yet again, more questions J Clin Oncol 21 21 2003 3897 3899
    • (2003) J Clin Oncol , vol.21 , Issue.21 , pp. 3897-3899
    • Ellis, L.M.1
  • 37
    • 0034255151 scopus 로고    scopus 로고
    • Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases
    • C.J. Bruns, W. Liu, D.W. Davis, R.M. Shaheen, D.J. McConkey, and M.R. Wilson Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases Cancer 89 2000 488 499
    • (2000) Cancer , vol.89 , pp. 488-499
    • Bruns, C.J.1    Liu, W.2    Davis, D.W.3    Shaheen, R.M.4    McConkey, D.J.5    Wilson, M.R.6
  • 38
    • 0032952010 scopus 로고    scopus 로고
    • Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    • L.E. Benjamin, D. Golijanin, A. Itin, D. Pode, and E. Keshet Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal J Clin Invest 103 2 1999 159 165
    • (1999) J Clin Invest , vol.103 , Issue.2 , pp. 159-165
    • Benjamin, L.E.1    Golijanin, D.2    Itin, A.3    Pode, D.4    Keshet, E.5
  • 39
    • 0033609922 scopus 로고    scopus 로고
    • Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src
    • H. He, V.J. Venema, X. Gu, R.C. Venema, M.B. Marrero, and R.B. Caldwell Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src J Biol Chem 274 1999 25130 25135
    • (1999) J Biol Chem , vol.274 , pp. 25130-25135
    • He, H.1    Venema, V.J.2    Gu, X.3    Venema, R.C.4    Marrero, M.B.5    Caldwell, R.B.6
  • 40
    • 0042386691 scopus 로고    scopus 로고
    • Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging
    • S.M. Galbraith, R.J. Maxwell, M.A. Lodge, G.M. Tozer, J. Wilson, and N.J. Taylor Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging J Clin Oncol 21 15 2003 2831 2842
    • (2003) J Clin Oncol , vol.21 , Issue.15 , pp. 2831-2842
    • Galbraith, S.M.1    Maxwell, R.J.2    Lodge, M.A.3    Tozer, G.M.4    Wilson, J.5    Taylor, N.J.6
  • 41
    • 0037106501 scopus 로고    scopus 로고
    • Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging
    • S.M. Galbraith, G.J.S. Rustin, M. Lodge, N.J. Taylor, J.J. Stirling, and M. Jameson Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging J Clin Oncol 20 18 2002 3826 3840
    • (2002) J Clin Oncol , vol.20 , Issue.18 , pp. 3826-3840
    • Galbraith, S.M.1    Rustin, G.J.S.2    Lodge, M.3    Taylor, N.J.4    Stirling, J.J.5    Jameson, M.6
  • 42
    • 0009347961 scopus 로고    scopus 로고
    • Dynamic contrast enhanced magnetic resonance imaging as a surrogate marker of efficacy in a phase I trial of a VEGF receptor tyrosine kinase inhibitor
    • B. Morgan, H. Ball, M. Buchert, G. Cherryman, J. Drevs, and M. Dugan Dynamic contrast enhanced magnetic resonance imaging as a surrogate marker of efficacy in a phase I trial of a VEGF receptor tyrosine kinase inhibitor Proc Am Assoc Cancer Res 42 2001 587
    • (2001) Proc Am Assoc Cancer Res , vol.42 , pp. 587
    • Morgan, B.1    Ball, H.2    Buchert, M.3    Cherryman, G.4    Drevs, J.5    Dugan, M.6
  • 43
    • 0035205433 scopus 로고    scopus 로고
    • Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
    • M.L. George, A.S. Dzik-Jurasz, A.R. Padhani, G. Brown, D.M. Tait, and S.A. Eccles Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer Br J Surg 88 12 2001 1628 1636
    • (2001) Br J Surg , vol.88 , Issue.12 , pp. 1628-1636
    • George, M.L.1    Dzik-Jurasz, A.S.2    Padhani, A.R.3    Brown, G.4    Tait, D.M.5    Eccles, S.A.6
  • 44
    • 5044222917 scopus 로고    scopus 로고
    • Conventional cytotoxic chemotherapy agents do not have acute antivascular effects, as measured by dynamic contrast enhanced MRI (DCE-MRI) [abstract]
    • K.J. Lankester, N.J. Taylor, J.J. Stirling, J. Boxall, M.O. Leach, and A.R. Padhani Conventional cytotoxic chemotherapy agents do not have acute antivascular effects, as measured by dynamic contrast enhanced MRI (DCE-MRI) [abstract] Proc Am Soc Clin Oncol 22 147 2003 a588
    • (2003) Proc Am Soc Clin Oncol , vol.22 , Issue.147
    • Lankester, K.J.1    Taylor, N.J.2    Stirling, J.J.3    Boxall, J.4    Leach, M.O.5    Padhani, A.R.6
  • 45
    • 2942602368 scopus 로고    scopus 로고
    • Response to anticancer treatment with docetaxel administered every 3 weeks and weekly is associated with functional assessment of changes in tumoral blood flow/perfusion
    • W. Wolfe, C.A. Presant, V. Waluch, and B.J. Le Berthon Response to anticancer treatment with docetaxel administered every 3 weeks and weekly is associated with functional assessment of changes in tumoral blood flow/perfusion Proc Am Assoc Cancer Res 44 2003 5343
    • (2003) Proc Am Assoc Cancer Res , vol.44 , pp. 5343
    • Wolfe, W.1    Presant, C.A.2    Waluch, V.3    Le Berthon, B.J.4
  • 47
    • 0035866818 scopus 로고    scopus 로고
    • Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma
    • A.F. DeVries, J. Griebel, C. Kremser, W. Judmaier, T. Gneiting, and A. Kreczy Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma Cancer Res 61 2001 2513 2516
    • (2001) Cancer Res , vol.61 , pp. 2513-2516
    • Devries, A.F.1    Griebel, J.2    Kremser, C.3    Judmaier, W.4    Gneiting, T.5    Kreczy, A.6
  • 48
    • 0042844535 scopus 로고    scopus 로고
    • Quantification of blood flow in brain tumors: Comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging
    • C. Warmuth, M. Günther, and C. Zimmer Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging Radiology 228 2003 523 532
    • (2003) Radiology , vol.228 , pp. 523-532
    • Warmuth, C.1    Günther, M.2    Zimmer, C.3
  • 49
    • 0034914228 scopus 로고    scopus 로고
    • State of the art: Technologic advances in abdominal MR imaging
    • M.T. Keogan, and R.R. Edelman State of the art: technologic advances in abdominal MR imaging Radiology 220 2001 310 320
    • (2001) Radiology , vol.220 , pp. 310-320
    • Keogan, M.T.1    Edelman, R.R.2
  • 50
    • 0034161989 scopus 로고    scopus 로고
    • Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies
    • A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K.H. Plate, and H.G. Augustin Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies Cancer Res 60 2000 1388 1393
    • (2000) Cancer Res , vol.60 , pp. 1388-1393
    • Eberhard, A.1    Kahlert, S.2    Goede, V.3    Hemmerlein, B.4    Plate, K.H.5    Augustin, H.G.6
  • 51
    • 0038376001 scopus 로고    scopus 로고
    • Imaging angiogenesis: From microscope to clinic
    • D.M. McDonald, and P.L. Choyke Imaging angiogenesis: from microscope to clinic Nat Med 9 6 2003 713 725
    • (2003) Nat Med , vol.9 , Issue.6 , pp. 713-725
    • McDonald, D.M.1    Choyke, P.L.2
  • 52
    • 0032900885 scopus 로고    scopus 로고
    • Regional blood flow, capillary permeability, and compartmental volumes: Measurement with dynamic CTâ€"initial experience
    • G. Brix, M.L. Bahner, U. Hoffmann, A. Horvath, and W. Schreiber Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CTâ€"initial experience Radiology 210 1 1999 269 276
    • (1999) Radiology , vol.210 , Issue.1 , pp. 269-276
    • Brix, G.1    Bahner, M.L.2    Hoffmann, U.3    Horvath, A.4    Schreiber, W.5
  • 53
    • 0032865983 scopus 로고    scopus 로고
    • Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review
    • K.A. Miles Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review Eur J Radiol 30 1999 198 205
    • (1999) Eur J Radiol , vol.30 , pp. 198-205
    • Miles, K.A.1
  • 54
    • 0036337092 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced functional imaging with multi-slice CT
    • P. Dawson Dynamic contrast-enhanced functional imaging with multi-slice CT Acad Radiol 9 Suppl 2 2002 S368 S370
    • (2002) Acad Radiol , vol.9 , Issue.2
    • Dawson, P.1
  • 55
    • 0001556502 scopus 로고    scopus 로고
    • Functional and metabolic imaging
    • V.T. DeVita S. Hellman S.A. Rosenberg 6th edition Lippincott Williams & Wilkins Philadelphia
    • M.G. Pomper Functional and metabolic imaging V.T. DeVita S. Hellman S.A. Rosenberg Cancer: principles & practice of oncology 6th edition 2001 Lippincott Williams & Wilkins Philadelphia 679 689
    • (2001) Cancer: Principles & Practice of Oncology , pp. 679-689
    • Pomper, M.G.1
  • 57
    • 0035810148 scopus 로고    scopus 로고
    • Brief report: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
    • H. Joensuu, P.J. Roberts, M. Sarlomo-Rikala, L.C. Andersson, and P. Tervahartiala Brief report: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 14 2001 1052 1056
    • (2001) N Engl J Med , vol.344 , Issue.14 , pp. 1052-1056
    • Joensuu, H.1    Roberts, P.J.2    Sarlomo-Rikala, M.3    Andersson, L.C.4    Tervahartiala, P.5
  • 58
    • 0036099568 scopus 로고    scopus 로고
    • Clinical measurement of blood flow in tumours using positron emission tomography: A review
    • H. Anderson, and P. Price Clinical measurement of blood flow in tumours using positron emission tomography: a review Nucl Med Comm 23 2 2002 131 138
    • (2002) Nucl Med Comm , vol.23 , Issue.2 , pp. 131-138
    • Anderson, H.1    Price, P.2
  • 59
    • 0042887593 scopus 로고    scopus 로고
    • Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate
    • H.L. Anderson, J.T. Yap, M.P. Miller, A. Robbins, T. Jones, and P.M. Price Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate J Clin Oncol 21 15 2003 2823 2830
    • (2003) J Clin Oncol , vol.21 , Issue.15 , pp. 2823-2830
    • Anderson, H.L.1    Yap, J.T.2    Miller, M.P.3    Robbins, A.4    Jones, T.5    Price, P.M.6
  • 60
    • 0037106384 scopus 로고    scopus 로고
    • Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin
    • R.S. Herbst, N.A. Mullani, D.W. Davis, K.R. Hess, D.J. McConkey, and C. Charnsangavej Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin J Clin Oncol 20 18 2002 3804 3814
    • (2002) J Clin Oncol , vol.20 , Issue.18 , pp. 3804-3814
    • Herbst, R.S.1    Mullani, N.A.2    Davis, D.W.3    Hess, K.R.4    McConkey, D.J.5    Charnsangavej, C.6
  • 61
    • 0034282515 scopus 로고    scopus 로고
    • Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model
    • J. Drevs, I. Hofmann, H. Hugenschmidt, C. Wittig, H. Madjar, and M. Müller Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model Cancer Res 60 2000 4819 4824
    • (2000) Cancer Res , vol.60 , pp. 4819-4824
    • Drevs, J.1    Hofmann, I.2    Hugenschmidt, H.3    Wittig, C.4    Madjar, H.5    Müller, M.6
  • 62
    • 0036100042 scopus 로고    scopus 로고
    • Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas
    • N. Lassau, S. Koscielny, M.F. Avril, A. Margulis, P. Duvillard, and T. De Baere Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas Am J Roentgenol 178 6 2002 1547 1551
    • (2002) Am J Roentgenol , vol.178 , Issue.6 , pp. 1547-1551
    • Lassau, N.1    Koscielny, S.2    Avril, M.F.3    Margulis, A.4    Duvillard, P.5    De Baere, T.6
  • 63
    • 0035154352 scopus 로고    scopus 로고
    • Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo
    • N. Lassau, S. Koscielny, P. Opolon, T. De Baere, P. Peronneau, and J. Leclere Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo Invest Radiol 36 2001 50 55
    • (2001) Invest Radiol , vol.36 , pp. 50-55
    • Lassau, N.1    Koscielny, S.2    Opolon, P.3    De Baere, T.4    Peronneau, P.5    Leclere, J.6
  • 64
    • 0031827027 scopus 로고    scopus 로고
    • Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US: Early experience
    • S. Huber, T. Helbich, J. Kettenbach, W. Dock, I. Zuna, and S. Delorme Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US: early experience Radiology 208 1998 485 489
    • (1998) Radiology , vol.208 , pp. 485-489
    • Huber, S.1    Helbich, T.2    Kettenbach, J.3    Dock, W.4    Zuna, I.5    Delorme, S.6
  • 65
    • 0037106374 scopus 로고    scopus 로고
    • Mechanisms and future directions for angiogenesis-based cancer therapies
    • F.A. Scappaticci Mechanisms and future directions for angiogenesis-based cancer therapies J Clin Oncol 20 18 2002 3906 3927
    • (2002) J Clin Oncol , vol.20 , Issue.18 , pp. 3906-3927
    • Scappaticci, F.A.1
  • 66
    • 0033737924 scopus 로고    scopus 로고
    • Measuring tumor blood flow with H(2)(15)O: Practical considerations
    • S.L. Bacharach, S.K. Libutti, and J.A. Carrasquillo Measuring tumor blood flow with H(2)(15)O: Practical considerations Nucl Med Biol 27 2000 671 676
    • (2000) Nucl Med Biol , vol.27 , pp. 671-676
    • Bacharach, S.L.1    Libutti, S.K.2    Carrasquillo, J.A.3
  • 67
    • 0036191012 scopus 로고    scopus 로고
    • Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI
    • D.L. Buckley Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI Magn Reson Med 47 3 2002 601 606
    • (2002) Magn Reson Med , vol.47 , Issue.3 , pp. 601-606
    • Buckley, D.L.1
  • 68
    • 5044232696 scopus 로고    scopus 로고
    • Biomarkers for the assessment of pharmacological activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): Comparison of per clinical data with results in phase I studies [abstract]
    • Boston, MA. November 19
    • Lee L, McSheehy P, Morgan B, Laird G, Allegrini P, Cozens R, et al. Biomarkers for the assessment of pharmacological activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): comparison of per clinical data with results in phase I studies [abstract]. Presented at the 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA. November 19, 2003
    • (2003) 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    • Lee, L.1    McSheehy, P.2    Morgan, B.3    Laird, G.4    Allegrini, P.5    Cozens, R.6
  • 69
    • 0036198715 scopus 로고    scopus 로고
    • Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semi-quantitative analysis
    • S.M. Galbraith, M.A. Lodge, N.J. Taylor, G.J. Rustin, S. Bentzen, and J.J. Stirling Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis NMR Biomed 15 2 2002 132 142
    • (2002) NMR Biomed , vol.15 , Issue.2 , pp. 132-142
    • Galbraith, S.M.1    Lodge, M.A.2    Taylor, N.J.3    Rustin, G.J.4    Bentzen, S.5    Stirling, J.J.6
  • 70
    • 0032893756 scopus 로고    scopus 로고
    • Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells
    • E.O. Aboagye, and Z.M. Bhujwalla Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells Cancer Res 59 1 1999 80 84
    • (1999) Cancer Res , vol.59 , Issue.1 , pp. 80-84
    • Aboagye, E.O.1    Bhujwalla, Z.M.2
  • 71
    • 0345600050 scopus 로고    scopus 로고
    • In vivo quantification of choline compounds in the breast with 1H MR spectroscopy
    • P.J. Bolan, S. Meisamy, E.H. Baker, J. Lin, T. Emory, and M. Nelson In vivo quantification of choline compounds in the breast with 1H MR spectroscopy Magn Reson Med 50 6 2003 1134 1143
    • (2003) Magn Reson Med , vol.50 , Issue.6 , pp. 1134-1143
    • Bolan, P.J.1    Meisamy, S.2    Baker, E.H.3    Lin, J.4    Emory, T.5    Nelson, M.6
  • 74
    • 0034652156 scopus 로고    scopus 로고
    • Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
    • A.M. Chinnaiyan, U. Prasad, S. Shankar, D.A. Hamstra, M. Shanaiah, and T.L. Chenevert Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proc Natl Acad Sci U S A 97 4 2000 1754 1759
    • (2000) Proc Natl Acad Sci U S a , vol.97 , Issue.4 , pp. 1754-1759
    • Chinnaiyan, A.M.1    Prasad, U.2    Shankar, S.3    Hamstra, D.A.4    Shanaiah, M.5    Chenevert, T.L.6
  • 75
    • 0036794291 scopus 로고    scopus 로고
    • Nuclear medicine applications in molecular imaging
    • F.G. Blankenberg, and H.W. Strauss Nuclear medicine applications in molecular imaging J Magn Reson Imaging 16 2002 352 361
    • (2002) J Magn Reson Imaging , vol.16 , pp. 352-361
    • Blankenberg, F.G.1    Strauss, H.W.2
  • 77
    • 0033995078 scopus 로고    scopus 로고
    • Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole
    • J.S. Rasey, J.J. Casciari, P.D. Hofstrand, M. Muzi, M.M. Graham, and L.K. Chin Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole Radiat Res 153 2000 84 92
    • (2000) Radiat Res , vol.153 , pp. 84-92
    • Rasey, J.S.1    Casciari, J.J.2    Hofstrand, P.D.3    Muzi, M.4    Graham, M.M.5    Chin, L.K.6
  • 78
    • 0032527120 scopus 로고    scopus 로고
    • 18F-labeled fluorouracil positron emission tomography and the prognosis of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil
    • M. Moehler, A. Dimitrakopoulou-Strauss, F. Gutzler, U. Raeth, L.G. Strauss, and W. Stremmel 18F-labeled fluorouracil positron emission tomography and the prognosis of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil Cancer 83 1998 245 253
    • (1998) Cancer , vol.83 , pp. 245-253
    • Moehler, M.1    Dimitrakopoulou-Strauss, A.2    Gutzler, F.3    Raeth, U.4    Strauss, L.G.5    Stremmel, W.6
  • 79
    • 0037108692 scopus 로고    scopus 로고
    • The development of [(124)I]iodinated-VG76e: A novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography
    • D.R. Collingridge, V.A. Carroll, M. Glaser, E.O. Aboagye, S. Osman, and O.C. Hutchinson The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography Cancer Res 62 20 2002 5912 5919
    • (2002) Cancer Res , vol.62 , Issue.20 , pp. 5912-5919
    • Collingridge, D.R.1    Carroll, V.A.2    Glaser, M.3    Aboagye, E.O.4    Osman, S.5    Hutchinson, O.C.6
  • 80
    • 0032890674 scopus 로고    scopus 로고
    • Breast cancer imaging with radiolabeled antibodies
    • D.M. Goldenberg, and H.A. Nabi Breast cancer imaging with radiolabeled antibodies Semin Nucl Med 29 1 1999 41 48
    • (1999) Semin Nucl Med , vol.29 , Issue.1 , pp. 41-48
    • Goldenberg, D.M.1    Nabi, H.A.2
  • 81
    • 0036337131 scopus 로고    scopus 로고
    • Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology
    • G.M. Lanza, D.R. Abendschein, X. Yu, P.M. Winter, K.K. Karukstis, and M.J. Scott Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology Acad Radiol 9 Suppl 2 2002 S330 S331
    • (2002) Acad Radiol , vol.9 , Issue.2
    • Lanza, G.M.1    Abendschein, D.R.2    Yu, X.3    Winter, P.M.4    Karukstis, K.K.5    Scott, M.J.6
  • 82
    • 0031862889 scopus 로고    scopus 로고
    • Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging
    • D.A. Sipkins, D.A. Cheresh, M.R. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C. Li Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 1998 623 626
    • (1998) Nat Med , vol.4 , pp. 623-626
    • Sipkins, D.A.1    Cheresh, D.A.2    Kazemi, M.R.3    Nevin, L.M.4    Bednarski, M.D.5    Li, K.C.6
  • 83
    • 0034924538 scopus 로고    scopus 로고
    • In vivo imaging of gene expression: MR and optical technologies
    • C. Bremmer, and R. Weissleder In vivo imaging of gene expression: MR and optical technologies Acad Radiol 8 2001 15 23
    • (2001) Acad Radiol , vol.8 , pp. 15-23
    • Bremmer, C.1    Weissleder, R.2
  • 85
    • 0032470386 scopus 로고    scopus 로고
    • Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
    • E.C. Unger, T.P. McCreery, R.H. Sweitzer, V.E. Caldwell, and Y. Wu Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent Invest Radiol 33 1998 886 892
    • (1998) Invest Radiol , vol.33 , pp. 886-892
    • Unger, E.C.1    McCreery, T.P.2    Sweitzer, R.H.3    Caldwell, V.E.4    Wu, Y.5
  • 86
    • 0032697682 scopus 로고    scopus 로고
    • Near-infrared optical imaging of protease activity for tumor detection
    • U. Mahmood, C.H. Tung, A. Bogdanov Jr, and R. Weissleder Near-infrared optical imaging of protease activity for tumor detection Radiology 213 1999 866 870
    • (1999) Radiology , vol.213 , pp. 866-870
    • Mahmood, U.1    Tung, C.H.2    Bogdanov Jr., A.3    Weissleder, R.4
  • 87
    • 0034646351 scopus 로고    scopus 로고
    • Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
    • V. Ntziachristos, A.G. Yodh, M. Schnall, and B. Chance Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement Proc Natl Acad Sci U S A 97 2000 2767 2772
    • (2000) Proc Natl Acad Sci U S a , vol.97 , pp. 2767-2772
    • Ntziachristos, V.1    Yodh, A.G.2    Schnall, M.3    Chance, B.4
  • 88
    • 23044530493 scopus 로고    scopus 로고
    • The myth of mechanism
    • T.V. Rajan The myth of mechanism Scientist 15 13 2001 6
    • (2001) Scientist , vol.15 , Issue.13 , pp. 6
    • Rajan, T.V.1
  • 89
    • 0041885413 scopus 로고    scopus 로고
    • Functional imaging in phase I studies: Decorations or decision making?
    • J.M. Collins Functional imaging in phase I studies: decorations or decision making? J Clin Oncol 21 15 2003 2807 2809
    • (2003) J Clin Oncol , vol.21 , Issue.15 , pp. 2807-2809
    • Collins, J.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.